AI and biotech drug development

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AI and biotech drug development

posted on Sep 03, 2023 11:18AM

https://www.mckinsey.com/featured-insights/the-next-normal/biotech

This post and article should probably be in the Off topic section but I am curious whether the Management team of both Zenith Epigenetics and RVX have looked to marketing both companies in the AI field if applicable seeing the huge buzz in the field , could cause some interest and good PR possibly

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply